What precautions should be taken for a child with hemophilia A ?

Question

Hello doctor,

My nephew, aged 11, has hemophilia A with a factor VIII level below one percent. He recently had joint swelling after a minor fall, and the doctor advised factor replacement.

How often do these infusions need to be given in children for prevention?
Also, can repeated infusions lead to inhibitor formation and make treatment less effective?
His school activities are limited; are there safe exercises he can still do?
We are finding the cost of factors quite high; is there any government aid or alternate long-acting therapy that reduces the frequency of these injections safely for kids?

Kindly suggest.

Answer 1

Hello,

Welcome to icliniq.com.

I understand your concern.

Our nephew’s condition, like severe hemophilia A with factor VIII levels below 1 % requires careful long-term management to prevent bleeding into joints and muscles.

Since he already developed joint swelling after a minor fall, this suggests that he needs regular prophylactic factor VIII infusions rather than treatment only during bleeds.

In children with severe hemophilia A, prophylaxis is usually given two to three times per week with standard (short-acting) factor VIII products, since the factor’s half-life is about eight to 12 hours.

The goal is to keep factor levels above one percent most of the time to prevent spontaneous bleeds and long-term joint damage (hemarthrosis).

You are right to ask about inhibitor formation, which is one of the biggest challenges in hemophilia care. About 20 to 30 % of children with severe hemophilia A can develop antibodies (inhibitors) against factor VIII, making replacement therapy less effective.

The risk is highest during the first 50 exposure days to the factor concentrate. To minimize this, it is important that infusions are done carefully under medical supervision, with proper dosing and monitoring.

If inhibitors do appear, special treatments like immune tolerance induction (ITI) or non-factor-based therapies (like Emicizumab) may be needed.

Regarding physical activity, it is actually beneficial for children with hemophilia to stay active to strengthen muscles and protect joints, as long as they avoid contact sports or activities with high injury risk (like football, hockey, or wrestling).

Safe options include swimming, walking, light cycling, and stretching or resistance exercises supervised by a physiotherapist familiar with hemophilia care.

These help improve coordination and reduce the risk of bleeding from accidental falls. You also mentioned the cost of factor replacement, which can be very high.

Many countries, including developing ones, have government-supported hemophilia programs that provide free or subsidized factor concentrates through public hospitals or national hemophilia foundations.

It is worth checking with your local Hemophilia Society or Ministry of Health for available support.

In addition, newer extended half-life factor VIII products (like Efmoroctocog alfa or Rurioctocog alfa pegol) and non–factor therapy such as Emicizumab (Hemlibra) have made management easier.

Emicizumab is particularly promising because it is given as a subcutaneous injection once weekly or even once every two to four weeks, and it dramatically reduces bleeding episodes, even in children with inhibitors.

So regular prophylactic therapy is key to protecting your nephew’s joints and quality of life. With the availability of longer-acting agents and national support programs, his treatment can be made safer, less frequent, and more affordable.

It would be best to discuss these newer options with his hematologist, who can tailor a plan that balances medical effectiveness, safety, and financial practicality for your family.

I hope this helps.

Thank you.